Company
Headquarters: Qingdao, China
Employees: 1,879
CN¥10.14 Billion
CNY as of Jan. 1, 2025
US$1.39 Billion
| Company | Market Cap (USD) |
|---|---|
| Abbott | $213.72 B |
| Stryker | $150.01 B |
| Boston Scientific Corporation | $149.80 B |
| Medtronic | $114.44 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $47.37 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Qingdao Haier Biomedical Co., Ltd. engages in the design, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples worldwide. The company offers freezers, pharmacy, blood bank, and vaccine refrigerators; cold/freezer rooms; liquid nitrogen containers; incubators; cryogenic consumables; and centrifuge products, as well as health care solutions. It also provides blood, vaccine, reagent, sample, and laboratory network solutions in agri and animal health sectors. The company was founded in 2005 and is based in Qingdao, China.
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | CN¥2.24 B |
| EBITDA | CN¥412.4 M |
| Gross Profit TTM | CN¥1.12 B |
| Profit Margin | 16.01% |
| Operating Margin | 14.02% |
| Quarterly Revenue Growth | 0.50% |
Qingdao Haier Biomedical Co. Ltd has the following listings and related stock indices.
Stock: SSE: 688139 wb_incandescent